The integration of artificial intelligence (AI) into healthcare systems marked a pivotal evolution in clinical analytics architectures and governance structures, transforming data-driven decision-making from siloed, retrospective analyses to dynamic, predictive, and integrated frameworks. This period witnessed rapid advancements in machine learning (ML) applications for healthcare infrastructure, encompassing electronic health records (EHRs), imaging diagnostics, population health management, and real-time monitoring systems. Key developments included the shift toward federated learning to address data privacy concerns, the emergence of explainable AI (XAI) to enhance clinical trustworthiness, and the standardization of regulatory pathways for AI as medical devices. Architecturally, healthcare systems evolved from static analytics pipelines—where data ingestion, model training, and inference occurred in isolated phases—to adaptive, closed-loop configurations that incorporate feedback mechanisms for continuous model refinement and human-AI collaboration. Governance structures are adapted accordingly, emphasizing ethical frameworks to mitigate bias, ensure data equity, and promote algorithmic accountability, particularly for underserved populations. This review synthesizes literature from this timeframe, highlighting how AI-enabled analytics architectures facilitated precision medicine by integrating multimodal data sources, such as genomics, wearables, and social determinants of health, into cohesive systems. Challenges in interoperability and scalability were addressed through consensus guidelines like CONSORT-AI and SPIRIT-AI, which promoted transparent reporting of AI interventions in clinical trials. Moreover, the COVID-19 pandemic accelerated AI deployment in pandemic response systems, underscoring the need for resilient architectures capable of handling real-time data surges and uncertainty communication. Governance evolved to include multi-stakeholder perspectives, from regulatory bodies such as the FDA to clinical practitioners, ensuring that AI tools align with evidence-based medicine. This narrative review provides an original systems-level framing, organizing the literature around data-to-decision cycles, infrastructural integration, and governance maturation. By examining cross-study insights, it reveals how AI has fostered intelligent healthcare ecosystems, reducing diagnostic bias across diverse cohorts and enhancing decision support without over-relying on black-box models. Ultimately, this synthesis underscores the transition from AI as a supplementary tool to a foundational element of healthcare systems, paving the way for equitable, efficient clinical analytics.
Sepsis remains a major cause of mortality in intensive care units worldwide, with an estimated 49 million cases and over 11 million deaths annually, highlighting the need for earlier detection to improve outcomes. This systematic review synthesizes evidence on machine learning models for early sepsis prediction in adult ICU patients from 2017 to 2021, focusing on prediction horizons, data modalities, and validation approaches. A comprehensive search of PubMed, Embase, IEEE Xplore, ACM Digital Library, and arXiv identified studies meeting criteria for ICU-based sepsis prediction with at least a 4-hour forecast window, following PRISMA guidelines. Of 1,478 records screened, 35 studies were included, with prediction horizons ranging from 4 to 24 hours and most relying on hourly vital sign data and internal validation. Reported performance varied widely depending on horizon length, data sampling, and validation rigor, with external validation generally producing lower but more realistic results. Overall, while machine learning models show promising predictive ability, limitations in generalizability and standardization remain, emphasizing the need for stronger validation frameworks and reporting practices to support clinical translation.
Sepsis continues to be a major contributor to morbidity and mortality among hospitalized patients globally, especially within intensive care and emergency departments, where rapid recognition is essential for improving survival through timely treatment. In recent years, machine learning approaches have gained attention for their ability to predict sepsis onset using routinely collected electronic health record data. This systematic review, conducted in accordance with PRISMA 2020 guidelines, synthesizes evidence from studies published between 2017 and 2025, focusing on model architectures, feature selection and engineering strategies, prediction time horizons, and validation methodologies. Searches across major biomedical and informatics databases identified 67 eligible studies. The included literature shows that logistic regression, ensemble tree-based algorithms, and deep learning models are most frequently applied for sepsis prediction tasks. However, the majority of studies rely on retrospective datasets with internal validation, while only a limited number incorporate prospective or real-world validation frameworks. Overall, although reported model performance is often strong in retrospective analyses, a consistent decline in accuracy is observed when models are evaluated in real clinical environments. These findings highlight that prospective validation and improved generalizability are still underdeveloped areas, underscoring the need for future research to emphasize real-time deployment and robust external validation before clinical integration.
Public health emergencies reveal critical weaknesses in healthcare supply chains, especially when PPE demand outpaces procurement and distribution capacity, making predictive analytics an important tool for forecasting demand and improving allocation during crises. This systematic review evaluates predictive analytics models for PPE demand forecasting and distribution optimization during public health emergencies, focusing on model types, data sources, validation approaches, performance metrics, equity considerations, and implementation readiness. Following PRISMA 2020 guidelines, searches were conducted in PubMed, Web of Science, Scopus, IEEE Xplore, and Google Scholar for studies published between 2017 and 2025, yielding 2,847 records, of which 35 met inclusion criteria. Included studies comprised time series and statistical models (34%), machine learning and hybrid approaches (29%), optimization methods (26%), and simulation or digital twin frameworks (11%), with limited evidence of real-world deployment. Overall, findings indicate that predictive analytics can enhance PPE supply chain resilience by improving demand forecasting, allocation decisions, and scenario testing, but widespread adoption is limited by poor data interoperability, insufficient prospective validation, weak equity integration, and limited operational integration into healthcare decision systems.
Federated and decentralized machine learning offer the potential to extract valuable healthcare insights from siloed data without requiring the centralization of sensitive patient records, addressing long-standing privacy and governance challenges. This critical review assesses federated learning in healthcare through three lenses: privacy-preserving technologies, incentive mechanisms, and regulatory compliance frameworks. It examines whether the claims in existing literature are substantiated by real-world evidence from healthcare settings. The review reveals considerable enthusiasm for federated learning but identifies gaps, including incomplete implementation of privacy technologies, theoretical incentive mechanisms, and regulatory compliance often assumed but not validated. Additionally, real-world deployments are limited in scale and duration. The review concludes that the gap between federated learning's theoretical potential and clinical application remains significant, with overstated privacy claims and a lack of established frameworks for incentives and compliance.